Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 12 Apr 2007 for Molecular Insight Pharmaceuticals, Inc., €32k.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Kim D. Lamon: trading record in brief
Our data holds just one disclosure by Kim D. Lamon, dated 12 April 2007, reporting an open-market purchase worth €32k in Molecular Insight Pharmaceuticals, Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kim D. Lamon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 3,000 shares@ US$14.00Common StockSEC:0001209191-07-023708:0Canonical exit: 2 May 2007 (T+90)
1 of 1 declaration
